Hot Features
Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or dis... Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee. The company was incorporated in 2004 and is based in Herzliya, Israel. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.47 | -22.0657276995 | 2.13 | 2.17 | 1.5351 | 33811 | 1.84136087 | CS |
| 4 | -0.78 | -31.9672131148 | 2.44 | 2.615 | 1.5351 | 32235 | 2.12070477 | CS |
| 12 | -1.56 | -48.4472049689 | 3.22 | 3.44 | 1.5351 | 14469 | 2.33927981 | CS |
| 26 | -5.74 | -77.5675675676 | 7.4 | 8.35 | 1.5351 | 17998 | 4.95333446 | CS |
| 52 | -5.74 | -77.5675675676 | 7.4 | 8.35 | 1.5351 | 17998 | 4.95333446 | CS |
| 156 | -5.74 | -77.5675675676 | 7.4 | 8.35 | 1.5351 | 17998 | 4.95333446 | CS |
| 260 | -5.74 | -77.5675675676 | 7.4 | 8.35 | 1.5351 | 17998 | 4.95333446 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.